MedTrace Logo

Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery

NCT06144112 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2025-07-20

No results posted yet for this study

Summary

We compared the time consumed for goal-directed management of hypofibrinogemia using two strategies during liver transplant (LT) surgery: a conventional cryoprecipitate-based strategy versus a lyophilized fibrinogen concentrate-based strategy

Conditions

Interventions

BIOLOGICAL

fresh frozen plasma

transfusion of fresh frozen plasma

BIOLOGICAL

prothrombin complex concentrate

prothrombin complex concentrate administration

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER

  • Konkuk University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06144112 on ClinicalTrials.gov